Krishna Hari Bhandari

694 total citations
16 papers, 594 citations indexed

About

Krishna Hari Bhandari is a scholar working on Pharmaceutical Science, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Krishna Hari Bhandari has authored 16 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 7 papers in Materials Chemistry and 6 papers in Molecular Biology. Recurrent topics in Krishna Hari Bhandari's work include Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (7 papers) and Bone health and treatments (6 papers). Krishna Hari Bhandari is often cited by papers focused on Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (7 papers) and Bone health and treatments (6 papers). Krishna Hari Bhandari collaborates with scholars based in South Korea and Canada. Krishna Hari Bhandari's co-authors include Madhuri Newa, Chul Soon Yong, Bong-Kyu Yoo, Won Seok Lyoo, Jong Soo Woo, Han Gon Choi, Michael R. Doschak, Jong Oh Kim, Ho‐Suk Choi and Tae‐Hyun Kwon and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Krishna Hari Bhandari

16 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishna Hari Bhandari South Korea 11 387 159 128 116 76 16 594
Madhuri Newa South Korea 11 387 1.0× 159 1.0× 126 1.0× 116 1.0× 76 1.0× 15 584
Bong-Kyu Yoo South Korea 12 384 1.0× 143 0.9× 95 0.7× 88 0.8× 52 0.7× 19 538
Naveen Chella India 16 416 1.1× 154 1.0× 214 1.7× 79 0.7× 44 0.6× 38 841
Michael M. Morgen United States 14 440 1.1× 172 1.1× 123 1.0× 54 0.5× 89 1.2× 19 662
Rishikesh M. Kulkarni United States 8 502 1.3× 110 0.7× 224 1.8× 47 0.4× 50 0.7× 10 965
Roy Haskell United States 12 483 1.2× 266 1.7× 129 1.0× 74 0.6× 101 1.3× 19 655
Hongze Piao China 10 453 1.2× 144 0.9× 133 1.0× 51 0.4× 32 0.4× 10 632
Marilyn Calderone France 8 477 1.2× 118 0.7× 91 0.7× 50 0.4× 125 1.6× 11 615
Eduardo Jule France 9 473 1.2× 127 0.8× 150 1.2× 49 0.4× 111 1.5× 10 712
Atsuo Miyagishima Japan 16 285 0.7× 113 0.7× 280 2.2× 63 0.5× 55 0.7× 36 777

Countries citing papers authored by Krishna Hari Bhandari

Since Specialization
Citations

This map shows the geographic impact of Krishna Hari Bhandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Hari Bhandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Hari Bhandari more than expected).

Fields of papers citing papers by Krishna Hari Bhandari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Hari Bhandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Hari Bhandari. The network helps show where Krishna Hari Bhandari may publish in the future.

Co-authorship network of co-authors of Krishna Hari Bhandari

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Hari Bhandari. A scholar is included among the top collaborators of Krishna Hari Bhandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Hari Bhandari. Krishna Hari Bhandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yang, Yang, et al.. (2017). Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats. Drug Delivery and Translational Research. 7(4). 482–496. 9 indexed citations
2.
Yang, Yang, Krishna Hari Bhandari, Arash Panahifar, & Michael R. Doschak. (2013). Synthesis, Characterization and Biodistribution Studies of 125I-Radioiodinated di-PEGylated Bone Targeting Salmon Calcitonin Analogue in Healthy Rats. Pharmaceutical Research. 31(5). 1146–1157. 12 indexed citations
3.
Newa, Madhuri, et al.. (2013). Expression, Characterization, and Evaluation of a RANK-Binding Single Chain Fraction Variable: An Osteoclast Targeting Drug Delivery Strategy. Molecular Pharmaceutics. 11(1). 81–89. 4 indexed citations
4.
Bhandari, Krishna Hari, et al.. (2011). Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats. Journal of Controlled Release. 158(1). 44–52. 35 indexed citations
5.
Newa, Madhuri, et al.. (2011). Antibody-Mediated “Universal” Osteoclast Targeting Platform using Calcitonin as a Model Drug. Pharmaceutical Research. 28(5). 1131–1143. 10 indexed citations
6.
Bhandari, Krishna Hari, Madhuri Newa, Hasan Uludağ, & Michael R. Doschak. (2010). Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon Calcitonin. International Journal of Pharmaceutics. 394(1-2). 26–34. 22 indexed citations
7.
Newa, Madhuri, Krishna Hari Bhandari, Jung‐Hoon Sung, et al.. (2008). Enhanced Dissolution of Ibuprofen Using Solid Dispersion with Polyethylene Glycol 20000. Drug Development and Industrial Pharmacy. 34(10). 1013–1021. 27 indexed citations
8.
Newa, Madhuri, Krishna Hari Bhandari, Jung‐Ae Kim, et al.. (2008). Preparation and Evaluation of Fast Dissolving Ibuprofen-Polyethylene Glycol 6000 Solid Dispersions. Drug Delivery. 15(6). 355–364. 30 indexed citations
9.
Newa, Madhuri, Krishna Hari Bhandari, Dong Hoon Oh, et al.. (2008). Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Archives of Pharmacal Research. 31(11). 1497–1507. 86 indexed citations
10.
Newa, Madhuri, Krishna Hari Bhandari, Jong Oh Kim, et al.. (2008). Enhancement of Solubility, Dissolution and Bioavailability of Ibuprofen in Solid Dispersion Systems. Chemical and Pharmaceutical Bulletin. 56(4). 569–574. 58 indexed citations
11.
Bhandari, Krishna Hari, Madhuri Newa, Jung Sun Kim, et al.. (2008). Evaluation of skin permeation and accumulation profiles of a highly lipophilic fatty ester. Archives of Pharmacal Research. 31(2). 242–249. 10 indexed citations
12.
Newa, Madhuri, Krishna Hari Bhandari, Dong Xun Li, et al.. (2008). Preparation and Evaluation of Immediate Release Ibuprofen Solid Dispersions Using Polyethylene Glycol 4000. Biological and Pharmaceutical Bulletin. 31(5). 939–945. 39 indexed citations
13.
Bhandari, Krishna Hari, Madhuri Newa, Jung Ae Kim, et al.. (2007). Preparation, Characterization and Evaluation of Coenzyme Q10 Binary Solid Dispersions for Enhanced Solubility and Dissolution. Biological and Pharmaceutical Bulletin. 30(6). 1171–1176. 39 indexed citations
14.
Newa, Madhuri, Krishna Hari Bhandari, Dong Li, et al.. (2007). Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. International Journal of Pharmaceutics. 343(1-2). 228–237. 190 indexed citations
15.
Bhandari, Krishna Hari, Madhuri Newa, Jung Sun Kim, et al.. (2007). Evaluation of Physicochemical Properties, Skin Permeation and Accumulation Profiles of Ketorolac Fatty Ester Prodrugs. Biological and Pharmaceutical Bulletin. 30(11). 2211–2216. 14 indexed citations
16.
Bhandari, Krishna Hari, Madhuri Newa, Jung Sun Kim, et al.. (2007). Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters.. PubMed. 10(3). 278–87. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Madhuri Newa Breakdown of academic impact, for papers by Bong-Kyu Yoo Breakdown of academic impact, for papers by Naveen Chella Breakdown of academic impact, for papers by Michael M. Morgen Breakdown of academic impact, for papers by Rishikesh M. Kulkarni Breakdown of academic impact, for papers by Roy Haskell Breakdown of academic impact, for papers by Hongze Piao Breakdown of academic impact, for papers by Marilyn Calderone Breakdown of academic impact, for papers by Eduardo Jule Breakdown of academic impact, for papers by Atsuo Miyagishima
Rankless by CCL
2026